Stock comparison
Pro Medicus Limited
PME.AX$22.02BHealthcare Market cap, Sector
Zimmer Biomet Holdings
ZBH$17.3BHealthcare Market cap, Sector
Overall winner
Pro Medicus Limited
PME.AX 70 ZBH
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
PME.AX7wins
0winsZBH
78B
D54
90A
D51
98A
D49
100A
F38
84B
F26
91A
F44
96A
D48
Side-by-side metrics
| Metric | PME.AX | ZBH |
|---|---|---|
| Market cap | Winner: $22.02B | $17.3B |
| P/E (TTM) | 147.6x | 21.4x Winner |
| EV/EBIT | 106.8x | 17.1x Winner |
| ROIC (TTM) | Winner: 42.56% | 4.98% |
| Gross margin | Winner: 99.85% | 70.03% |
| Net margin | Winner: 54.12% | 9.05% |
| Revenue CAGR 5y | Winner: 31.61% | 4.79% |
| EPS CAGR 5y | Winner: 37.34% | 16.54% |
| Debt / Equity | Winner: 0.0x | 0.5x |
| Dividend yield | - | 1.15% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
PME.AX leads on
- Debt / Equity0.0xvs 0.5x+98%
- ROIC (TTM)42.56%vs 4.98%+88%
- Revenue CAGR 5y31.61%vs 4.79%+85%
- Net margin54.12%vs 9.05%+83%
ZBH leads on
- P/E (TTM)21.4xvs 147.6x+85%
- EV/EBIT17.1xvs 106.8x+84%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.